Role of angiotensin II in extracellular matrix and transforming growth factor-β1 expression in hypertensive rats

The in vivo effects of alacepril (1-[(S)-3-acetylthio-2-methylpropanoyl]- L-prolyl- L-phenylalanine), an angiotensin converting enzyme inhibitor, and SC-52458 (5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(1H-tetrazol-5-ylphenyl)]pyridine), an angiotensin AT 1 receptor antagonist, were examine...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmacology. Molecular pharmacology section Vol. 269; no. 1; pp. 115 - 119
Main Authors Ohta, Kensuke, Kim, Shokei, Hamaguchi, Akinori, Yukimura, Tokihito, Miura, Katsuyuki, Takaori, Kazuo, Iwao, Hiroshi
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.09.1994
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The in vivo effects of alacepril (1-[(S)-3-acetylthio-2-methylpropanoyl]- L-prolyl- L-phenylalanine), an angiotensin converting enzyme inhibitor, and SC-52458 (5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(1H-tetrazol-5-ylphenyl)]pyridine), an angiotensin AT 1 receptor antagonist, were examined on the cardiac and aortic gene expressions of extracellular matrices and TGF-β1 in young spontaneously hypertensive rats (SHR). In SHR, types I and III collagen mRNAs were increased in the left ventricle, and in contrast, fibronectin, collagen IV, and transforming growth factor-β1 (TGF-β1) mRNAs were increased in aorta, compared with those in Wistar-Kyoto rats. All the enhanced mRNAs in both organs in SHR were significantly inhibited by the short-term treatment with the above two drugs. Thus, angiotensin AT 1 receptor may play an important role in the regulation of extracellular matrices and TGF-β1 expressions in SHR.
ISSN:0922-4106
DOI:10.1016/0922-4106(94)90033-7